Graham Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$772K	Buy	55,196 +37,013	+204%	+$517K	0.01%	630
2025 Q1	$245K	Buy	18,183 +5,283	+41%	+$71.2K	﹤0.01%	1034
2024 Q4	$247K	Sell	12,900 -1,533	-11%	-$29.4K	﹤0.01%	982
2024 Q3	$328K	Sell	14,433 -8,011	-36%	-$182K	0.01%	719
2024 Q2	$292K	Buy	+22,444	New	+$292K	0.01%	719